158 related articles for article (PubMed ID: 34750738)
1. Prolonged hypoxia switched on cancer stem cell-like plasticity in HepG2 tumourspheres cultured in serum-free media.
Ayob AZ; Ramasamy TS
In Vitro Cell Dev Biol Anim; 2021 Oct; 57(9):896-911. PubMed ID: 34750738
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
Schöning JP; Monteiro M; Gu W
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.
Ibrahim AA; Schmithals C; Kowarz E; Köberle V; Kakoschky B; Pleli T; Kollmar O; Nitsch S; Waidmann O; Finkelmeier F; Zeuzem S; Korf HW; Schmid T; Weigert A; Kronenberger B; Marschalek R; Piiper A
Clin Cancer Res; 2017 Jul; 23(14):3896-3905. PubMed ID: 28167508
[No Abstract] [Full Text] [Related]
4. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
Mimeault M; Batra SK
J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.
Kim MC; Hwang SH; Kim NY; Lee HS; Ji S; Yang Y; Kim Y
BMC Cancer; 2018 Aug; 18(1):819. PubMed ID: 30111297
[TBL] [Abstract][Full Text] [Related]
7. The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.
Myszczyszyn A; Czarnecka AM; Matak D; Szymanski L; Lian F; Kornakiewicz A; Bartnik E; Kukwa W; Kieda C; Szczylik C
Stem Cell Rev Rep; 2015 Dec; 11(6):919-43. PubMed ID: 26210994
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
[TBL] [Abstract][Full Text] [Related]
9. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration.
Yang X; Yang S; Wang C; Kuang S
J Biol Chem; 2017 Apr; 292(14):5981-5991. PubMed ID: 28232488
[TBL] [Abstract][Full Text] [Related]
10. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.
Bao B; Azmi AS; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Sarkar FH
Biochim Biophys Acta; 2012 Dec; 1826(2):272-96. PubMed ID: 22579961
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
[TBL] [Abstract][Full Text] [Related]
13. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.
Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS
Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657
[TBL] [Abstract][Full Text] [Related]
14. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
15. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.
Heddleston JM; Li Z; McLendon RE; Hjelmeland AB; Rich JN
Cell Cycle; 2009 Oct; 8(20):3274-84. PubMed ID: 19770585
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells and hypoxia-inducible factors (Review).
Tong WW; Tong GH; Liu Y
Int J Oncol; 2018 Aug; 53(2):469-476. PubMed ID: 29845228
[TBL] [Abstract][Full Text] [Related]
17. CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.
Johansson E; Grassi ES; Pantazopoulou V; Tong B; Lindgren D; Berg TJ; Pietras EJ; Axelson H; Pietras A
Cell Rep; 2017 Aug; 20(7):1641-1653. PubMed ID: 28813675
[TBL] [Abstract][Full Text] [Related]
18. HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.
Marhold M; Tomasich E; El-Gazzar A; Heller G; Spittler A; Horvat R; Krainer M; Horak P
Mol Cancer Res; 2015 Mar; 13(3):556-64. PubMed ID: 25349289
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
Cammarata PR; Neelam S; Brooks MM
Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
[TBL] [Abstract][Full Text] [Related]
20. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
